Inactive Instrument

Highlights Immunovant, Inc. Nasdaq

Equities

US45258J2015

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

Sector Update: Health Care Stocks Mixed Pre-Bell Thursday	30/05	MT
Immunovant Q4 Loss Widens -- Shares Fall After-Hours	30/05	MT
Immunovant, Inc. Reports Earnings Results for the Full Year Ended March 31, 2024	30/05	CI
Immunovant, Inc. Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	30/05	CI
Immunovant Posts Narrower Fiscal Q3 Loss	12/02	MT
Immunovant, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	12/02	CI
North American Morning Briefing : Stock Futures -2-	09/02	DJ
North American Morning Briefing : Jobs Report Tops -2-	02/02	DJ
Immunovant, Inc. Announces Results from the Initial Cohort of Patients in an Ongoing 24-Week Phase 2 Clinical Trial of Batoclimab in Patients with Graves' Disease Meaningfully Exceeded 50% Response Rates	21/12	CI
Immunovant, Inc. Announces Initial Data from 600 Mg MAD Cohort of A Phase 1 Clinical Trial of IMVT-1402 in Healthy Adults	28/11	CI
Immunovant, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	09/11	CI
Immunovant, Inc. Announces Positive Initial IMVT-1402 Phase 1 SAD and 300 mg Subcutaneous MAD Results	26/23/26	CI
Immunovant, Inc. Reports Earnings Results for the First Quarter Ended June 30, 2023	10/23/10	CI
Immunovant, Inc. Reports Earnings Results for the Full Year Ended March 31, 2023	22/23/22	CI
Immunovant, Inc. Reports Earnings Results for the Fourth Quarter Ended March 31, 2023	22/23/22	CI
Immunovant's Fiscal Q3 Loss Widens	03/23/03	MT
Immunovant, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	03/23/03	CI
Immunovant's Fiscal Q2 Loss Widens	04/22/04	MT
Immunovant, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	04/22/04	CI
Earnings Flash (IMVT) IMMUNOVANT Posts Q2 Loss $-0.41	04/22/04	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Immunovant, Inc. Nasdaq

Equities

US45258J2015

Highlights

Filters